"cancer biomarker" trang 11 - tải miễn phí từ tailieuXANH
Haemoglobin level increase as an efficacy biomarker during axitinib treatment for metastatic renal cell carcinoma: A retrospective study

Haemoglobin level increase as an efficacy biomarker during axitinib treatment for metastatic renal cell carcinoma: A retrospective study
8    59    0
INFORM2 NivEnt: The first trial of the INFORM2 biomarker driven phase I/II trial series: The combination of nivolumab and entinostat in children and adolescents with refractory high-risk malignancies

INFORM2 NivEnt: The first trial of the INFORM2 biomarker driven phase I/II trial series: The combination of nivolumab and entinostat in children and adolescents with refractory high-risk malignancies
11    79    0
Eosinophil-cationic protein - a novel liquid prognostic biomarker in melanoma

Eosinophil-cationic protein - a novel liquid prognostic biomarker in melanoma
7    62    0
A novel score based on serum apolipoprotein A-1 and C-reactive protein is a prognostic biomarker in hepatocellular carcinoma patients

A novel score based on serum apolipoprotein A-1 and C-reactive protein is a prognostic biomarker in hepatocellular carcinoma patients
13    46    0
Tumor classification and biomarker discovery based on the 5’isomiR expression level

Tumor classification and biomarker discovery based on the 5’isomiR expression level
10    62    0
Genome-wide copy number alteration and VEGFA amplification of circulating cell-free DNA as a biomarker in advanced hepatocellular carcinoma patients treated with Sorafenib

Genome-wide copy number alteration and VEGFA amplification of circulating cell-free DNA as a biomarker in advanced hepatocellular carcinoma patients treated with Sorafenib
13    52    0
Circulating tumor cells with karyotyping as a novel biomarker for diagnosis and treatment of nasopharyngeal carcinoma

Circulating tumor cells with karyotyping as a novel biomarker for diagnosis and treatment of nasopharyngeal carcinoma
12    55    0
Protocol of the PANCALYZE trial: A multicenter, prospective study investigating the tumor biomarkers CXCR4, SMAD4, SOX9 and IFIT3 in patients with resected pancreatic adenocarcinoma to predict the pattern of recurrence of the disease

Protocol of the PANCALYZE trial: A multicenter, prospective study investigating the tumor biomarkers CXCR4, SMAD4, SOX9 and IFIT3 in patients with resected pancreatic adenocarcinoma to predict the pattern of recurrence of the disease
9    47    0
SPARC expression in patients with high-risk localized soft tissue sarcoma treated on a randomized phase II trial of neo/adjuvant chemotherapy

SPARC expression in patients with high-risk localized soft tissue sarcoma treated on a randomized phase II trial of neo/adjuvant chemotherapy
8    50    0
Intrahepatic cholangiocarcinoma prognostic determination using preoperative serum C-reactive protein levels

Intrahepatic cholangiocarcinoma prognostic determination using preoperative serum C-reactive protein levels
10    53    0
Assessment of human papillomavirus E6/E7 oncogene expression as cervical disease biomarker

Assessment of human papillomavirus E6/E7 oncogene expression as cervical disease biomarker
7    49    0
A systematic search strategy identifies cubilin as independent prognostic marker for renal cell carcinoma

A systematic search strategy identifies cubilin as independent prognostic marker for renal cell carcinoma
9    51    0
A pharmacogenetic pilot study reveals MTHFR, DRD3, and MDR1 polymorphisms as biomarker candidates for slow atorvastatin metabolizers

A pharmacogenetic pilot study reveals MTHFR, DRD3, and MDR1 polymorphisms as biomarker candidates for slow atorvastatin metabolizers
13    65    0
FDG PET/CT as a prognostic biomarker in the era of molecular-targeting therapies: Max SUVmax predicts survival of patients with advanced renal cell carcinoma

FDG PET/CT as a prognostic biomarker in the era of molecular-targeting therapies: Max SUVmax predicts survival of patients with advanced renal cell carcinoma
7    72    0
Organic Cation Transporter 1 (OCT1) mRNA expression in hepatocellular carcinoma as a biomarker for sorafenib treatment

Organic Cation Transporter 1 (OCT1) mRNA expression in hepatocellular carcinoma as a biomarker for sorafenib treatment
8    48    0
Single nucleotide polymorphism rs13042395 in the SLC52A3 gene as a biomarker for regional lymph node metastasis and relapse-free survival of esophageal squamous cell carcinoma patients

Single nucleotide polymorphism rs13042395 in the SLC52A3 gene as a biomarker for regional lymph node metastasis and relapse-free survival of esophageal squamous cell carcinoma patients
11    50    0
Clinicopathological and prognostic significance of GPX2 protein expression in esophageal squamous cell carcinoma

Clinicopathological and prognostic significance of GPX2 protein expression in esophageal squamous cell carcinoma
8    55    0
Interleukin-8 is not a predictive biomarker for the development of the acute promyelocytic leukemia differentiation syndrome

Interleukin-8 is not a predictive biomarker for the development of the acute promyelocytic leukemia differentiation syndrome
7    71    0
E-cadherin as a potential biomarker of malignant transformation in oral leukoplakia: A retrospective cohort study

E-cadherin as a potential biomarker of malignant transformation in oral leukoplakia: A retrospective cohort study
7    69    0
Prognostic impact of urokinase-type plasminogen activator system components in clear cell renal cell carcinoma patients without distant metastasis

Prognostic impact of urokinase-type plasminogen activator system components in clear cell renal cell carcinoma patients without distant metastasis
12    77    0
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.